• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Chronic abdominal pain may indicate fructose intolerance

Article

Children who suffer from recurrent or functional abdominal pain may need to be tested for fructose intolerance.

Children who suffer from recurrent or functional abdominal pain may need to be tested for fructose intolerance. In a recent study by researchers at Mary Bridge Children's Hospital and Health Center in Tacoma, Washington, more than half (54%) of the 245 patients aged 2 to 18 years (mean age, 11 years) who were seen for unexplained chronic abdominal pain tested positive for fructose intolerance. Most (62%) patients were female.

Testing was done via a breath hydrogen test. Patients received a standard dose of 1 g/kg fructose to a maximum of 25 g. Using a microlyzer self-correcting model SC QuinTron machine, hydrogen and methane levels were tested at 30, 60, and 90 minutes. A level of 20 ppm above baseline was considered a positive result.

Fructose intolerance is effectively managed with a low-fructose diet. All patients in the study who tested positive met with a registered dietician for a nutrition consult, and 68% of patients said their symptoms (pain, constipation, gas or bloating, diarrhea) were resolved through a modified diet.

Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.